Jump to content
 







Main menu
   


Navigation  



Main page
Contents
Current events
Random article
About Wikipedia
Contact us
Donate
 




Contribute  



Help
Learn to edit
Community portal
Recent changes
Upload file
 








Search  

































Create account

Log in
 









Create account
 Log in
 




Pages for logged out editors learn more  



Contributions
Talk
 

















Editing Β-Hydroxybutyric acid

















Article
Talk
 

















Read
Edit
View history
 








Tools
   


Actions  



Read
Edit
View history
 




General  



What links here
Related changes
Upload file
Special pages
Page information
Get shortened URL
Download QR code
Wikidata item
 
















Appearance
   

 










You are not logged in. Your IP address will be publicly visible if you make any edits. If you log inorcreate an account, your edits will be attributed to a username, among other benefits.

 Content that violates any copyrights will be deleted. Encyclopedic content must be verifiable through citations to reliable sources.


Latest revision Your text
Line 66: Line 66:

<small>D</small>-β-Hydroxybutyric acid, along with [[butyric acid]], are the two primary [[endogenous]] [[agonist]]s of [[hydroxycarboxylic acid receptor&nbsp;2]] (HCA<sub>2</sub>), a {{nowrap|[[Gi alpha subunit|G<sub>i/o</sub>-coupled]]}} [[GPCR]].<ref name="IUPHAR's comprehensive 2011 review on HCARs"/><ref name="IUPHAR-DB HCAR family page"/><ref name="β-D-hydroxybutyric acid IUPHAR">{{cite web|title=β-D-hydroxybutyric acid: Biological activity|url=http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=1593|website=IUPHAR/BPS Guide to Pharmacology|publisher=International Union of Basic and Clinical Pharmacology|access-date=5 February 2018}}</ref>

<small>D</small>-β-Hydroxybutyric acid, along with [[butyric acid]], are the two primary [[endogenous]] [[agonist]]s of [[hydroxycarboxylic acid receptor&nbsp;2]] (HCA<sub>2</sub>), a {{nowrap|[[Gi alpha subunit|G<sub>i/o</sub>-coupled]]}} [[GPCR]].<ref name="IUPHAR's comprehensive 2011 review on HCARs"/><ref name="IUPHAR-DB HCAR family page"/><ref name="β-D-hydroxybutyric acid IUPHAR">{{cite web|title=β-D-hydroxybutyric acid: Biological activity|url=http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?tab=biology&ligandId=1593|website=IUPHAR/BPS Guide to Pharmacology|publisher=International Union of Basic and Clinical Pharmacology|access-date=5 February 2018}}</ref>



β-Hydroxybutyric acid is able to cross the [[blood-brain-barrier]] into the [[central nervous system]].<ref name="pmid27253067">{{cite journal | vauthors = Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Abou Haidar E, Stringer T, Ulja D, Karuppagounder SS, Holson EB, Ratan RR, Ninan I, Chao MV | display-authors = 6 | title = Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate | journal = eLife | volume = 5 | date = June 2016 | pmid = 27253067 | pmc = 4915811 | doi = 10.7554/eLife.15092 |doi-access=free }}</ref> Levels of β-hydroxybutyric acid increase in the [[liver]], [[heart]], [[muscle]], [[brain]], and other tissues with [[exercise]], [[calorie restriction]], [[fasting]], and [[ketogenic diet]]s.<ref name="pmid27253067" /> The compound has been found to act as a [[histone deacetylase inhibitor|histone deacetylase (HDAC) inhibitor]].<ref name="pmid27253067" /> Through inhibition of the HDAC class I [[isoenzyme]]s [[HDAC2]] and [[HDAC3]], β-hydroxybutyric acid has been found to increase [[brain-derived neurotrophic factor]] (BDNF) levels and [[TrkB]] [[cell signaling|signaling]] in the [[hippocampus]].<ref name="pmid27253067" /> Moreover, a rodent study found that prolonged exercise increases plasma β-hydroxybutyrate concentrations, which induces [[promoter (genetics)|promoters]] of the BDNF gene in the hippocampus.<ref name="pmid27253067" /> These findings may have clinical relevance in the treatment of [[depression (mood)|depression]], [[anxiety]], and [[cognitive impairment]].<ref name="pmid27253067"/>

β-Hydroxybutyric acid is able to cross the [[blood-brain-barrier]] into the [[central nervous system]].<ref name="pmid27253067">{{cite journal | vauthors = Sleiman SF, Henry J, Al-Haddad R, El Hayek L, Abou Haidar E, Stringer T, Ulja D, Karuppagounder SS, Holson EB, Ratan RR, Ninan I, Chao MV | display-authors = 6 | title = Exercise promotes the expression of brain derived neurotrophic factor (BDNF) through the action of the ketone body β-hydroxybutyrate | journal = eLife | volume = 5 | date = June 2016 | pmid = 27253067 | pmc = 4915811 | doi = 10.7554/eLife.15092 }}</ref> Levels of β-hydroxybutyric acid increase in the [[liver]], [[heart]], [[muscle]], [[brain]], and other tissues with [[exercise]], [[calorie restriction]], [[fasting]], and [[ketogenic diet]]s.<ref name="pmid27253067" /> The compound has been found to act as a [[histone deacetylase inhibitor|histone deacetylase (HDAC) inhibitor]].<ref name="pmid27253067" /> Through inhibition of the HDAC class I [[isoenzyme]]s [[HDAC2]] and [[HDAC3]], β-hydroxybutyric acid has been found to increase [[brain-derived neurotrophic factor]] (BDNF) levels and [[TrkB]] [[cell signaling|signaling]] in the [[hippocampus]].<ref name="pmid27253067" /> Moreover, a rodent study found that prolonged exercise increases plasma β-hydroxybutyrate concentrations, which induces [[promoter (genetics)|promoters]] of the BDNF gene in the hippocampus.<ref name="pmid27253067" /> These findings may have clinical relevance in the treatment of [[depression (mood)|depression]], [[anxiety]], and [[cognitive impairment]].<ref name="pmid27253067"/>



In [[epilepsy]] patients on the ketogenic diet, blood β-hydroxybutyrate levels correlate best with degree of [[seizure]] control. The threshold for optimal [[anticonvulsant]] effect appears to be approximately 4&nbsp;mmol/L.<ref name="pmid11198492">{{cite journal | vauthors = Gilbert DL, Pyzik PL, Freeman JM | title = The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones | journal = Journal of Child Neurology | volume = 15 | issue = 12 | pages = 787–790 | date = December 2000 | pmid = 11198492 | doi = 10.1177/088307380001501203 | s2cid = 46659339 }}</ref>

In [[epilepsy]] patients on the ketogenic diet, blood β-hydroxybutyrate levels correlate best with degree of [[seizure]] control. The threshold for optimal [[anticonvulsant]] effect appears to be approximately 4&nbsp;mmol/L.<ref name="pmid11198492">{{cite journal | vauthors = Gilbert DL, Pyzik PL, Freeman JM | title = The ketogenic diet: seizure control correlates better with serum beta-hydroxybutyrate than with urine ketones | journal = Journal of Child Neurology | volume = 15 | issue = 12 | pages = 787–790 | date = December 2000 | pmid = 11198492 | doi = 10.1177/088307380001501203 | s2cid = 46659339 }}</ref>

By publishing changes, you agree to the Terms of Use, and you irrevocably agree to release your contribution under the CC BY-SA 4.0 License and the GFDL. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel Editing help (opens in new window)

Copy and paste: – — ° ′ ″ ≈ ≠ ≤ ≥ ± − × ÷ ← → · §   Cite your sources: <ref></ref>


{{}}   {{{}}}   |   []   [[]]   [[Category:]]   #REDIRECT [[]]   &nbsp;   <s></s>   <sup></sup>   <sub></sub>   <code></code>   <pre></pre>   <blockquote></blockquote>   <ref></ref> <ref name="" />   {{Reflist}}   <references />   <includeonly></includeonly>   <noinclude></noinclude>   {{DEFAULTSORT:}}   <nowiki></nowiki>   <!-- -->   <span class="plainlinks"></span>


Symbols: ~ | ¡ ¿ † ‡ ↔ ↑ ↓ • ¶   # ∞   ‹› «»   ¤ ₳ ฿ ₵ ¢ ₡ ₢ $ ₫ ₯ € ₠ ₣ ƒ ₴ ₭ ₤ ℳ ₥ ₦ № ₧ ₰ £ ៛ ₨ ₪ ৳ ₮ ₩ ¥   ♠ ♣ ♥ ♦   𝄫 ♭ ♮ ♯ 𝄪   © ® ™
Latin: A a Á á À à  â Ä ä Ǎ ǎ Ă ă Ā ā à ã Å å Ą ą Æ æ Ǣ ǣ   B b   C c Ć ć Ċ ċ Ĉ ĉ Č č Ç ç   D d Ď ď Đ đ Ḍ ḍ Ð ð   E e É é È è Ė ė Ê ê Ë ë Ě ě Ĕ ĕ Ē ē Ẽ ẽ Ę ę Ẹ ẹ Ɛ ɛ Ǝ ǝ Ə ə   F f   G g Ġ ġ Ĝ ĝ Ğ ğ Ģ ģ   H h Ĥ ĥ Ħ ħ Ḥ ḥ   I i İ ı Í í Ì ì Î î Ï ï Ǐ ǐ Ĭ ĭ Ī ī Ĩ ĩ Į į Ị ị   J j Ĵ ĵ   K k Ķ ķ   L l Ĺ ĺ Ŀ ŀ Ľ ľ Ļ ļ Ł ł Ḷ ḷ Ḹ ḹ   M m Ṃ ṃ   N n Ń ń Ň ň Ñ ñ Ņ ņ Ṇ ṇ Ŋ ŋ   O o Ó ó Ò ò Ô ô Ö ö Ǒ ǒ Ŏ ŏ Ō ō Õ õ Ǫ ǫ Ọ ọ Ő ő Ø ø Œ œ   Ɔ ɔ   P p   Q q   R r Ŕ ŕ Ř ř Ŗ ŗ Ṛ ṛ Ṝ ṝ   S s Ś ś Ŝ ŝ Š š Ş ş Ș ș Ṣ ṣ ß   T t Ť ť Ţ ţ Ț ț Ṭ ṭ Þ þ   U u Ú ú Ù ù Û û Ü ü Ǔ ǔ Ŭ ŭ Ū ū Ũ ũ Ů ů Ų ų Ụ ụ Ű ű Ǘ ǘ Ǜ ǜ Ǚ ǚ Ǖ ǖ   V v   W w Ŵ ŵ   X x   Y y Ý ý Ŷ ŷ Ÿ ÿ Ỹ ỹ Ȳ ȳ   Z z Ź ź Ż ż Ž ž   ß Ð ð Þ þ Ŋ ŋ Ə ə
Greek: Ά ά Έ έ Ή ή Ί ί Ό ό Ύ ύ Ώ ώ   Α α Β β Γ γ Δ δ   Ε ε Ζ ζ Η η Θ θ   Ι ι Κ κ Λ λ Μ μ   Ν ν Ξ ξ Ο ο Π π   Ρ ρ Σ σ ς Τ τ Υ υ   Φ φ Χ χ Ψ ψ Ω ω   {{Polytonic|}}
Cyrillic: А а Б б В в Г г   Ґ ґ Ѓ ѓ Д д Ђ ђ   Е е Ё ё Є є Ж ж   З з Ѕ ѕ И и І і   Ї ї Й й Ј ј К к   Ќ ќ Л л Љ љ М м   Н н Њ њ О о П п   Р р С с Т т Ћ ћ   У у Ў ў Ф ф Х х   Ц ц Ч ч Џ џ Ш ш   Щ щ Ъ ъ Ы ы Ь ь   Э э Ю ю Я я   ́
IPA: t̪ d̪ ʈ ɖ ɟ ɡ ɢ ʡ ʔ   ɸ β θ ð ʃ ʒ ɕ ʑ ʂ ʐ ç ʝ ɣ χ ʁ ħ ʕ ʜ ʢ ɦ   ɱ ɳ ɲ ŋ ɴ   ʋ ɹ ɻ ɰ   ʙ ⱱ ʀ ɾ ɽ   ɫ ɬ ɮ ɺ ɭ ʎ ʟ   ɥ ʍ ɧ   ʼ   ɓ ɗ ʄ ɠ ʛ   ʘ ǀ ǃ ǂ ǁ   ɨ ʉ ɯ   ɪ ʏ ʊ   ø ɘ ɵ ɤ   ə ɚ   ɛ œ ɜ ɝ ɞ ʌ ɔ   æ   ɐ ɶ ɑ ɒ   ʰ ʱ ʷ ʲ ˠ ˤ ⁿ ˡ   ˈ ˌ ː ˑ ̪   {{IPA|}}

Wikidata entities used in this page

Pages transcluded onto the current version of this page (help):

This page is a member of 11 hidden categories (help):


Retrieved from "https://en.wikipedia.org/wiki/Β-Hydroxybutyric_acid"







Privacy policy

About Wikipedia

Disclaimers

Contact Wikipedia

Code of Conduct

Developers

Statistics

Cookie statement

Mobile view



Wikimedia Foundation
Powered by MediaWiki